Original
Coste-efectividad de la polipíldora CNIC frente a los monocomponentes separados en prevención secundaria cardiovascular en España
Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain
Leído
1053
Vecesse ha leído el artículo
84
Total PDF
969
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 0 | 2 |
| 2025 5 | 69 | 4 | 73 |
| 2025 4 | 68 | 10 | 78 |
| 2025 3 | 56 | 1 | 57 |
| 2025 2 | 53 | 1 | 54 |
| 2025 1 | 44 | 0 | 44 |
| 2024 12 | 39 | 1 | 40 |
| 2024 11 | 57 | 2 | 59 |
| 2024 10 | 39 | 2 | 41 |
| 2024 9 | 61 | 9 | 70 |
| 2024 8 | 48 | 1 | 49 |
| 2024 7 | 50 | 4 | 54 |
| 2024 6 | 40 | 2 | 42 |
| 2024 5 | 54 | 5 | 59 |
| 2024 4 | 55 | 9 | 64 |
| 2024 3 | 41 | 7 | 48 |
| 2024 2 | 81 | 10 | 91 |
| 2024 1 | 18 | 5 | 23 |
| 2023 10 | 6 | 1 | 7 |
| 2023 9 | 52 | 0 | 52 |
| 2023 8 | 8 | 2 | 10 |
| 2023 7 | 28 | 8 | 36 |
Mostrar todo
